147 related articles for article (PubMed ID: 32964748)
21. Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies.
Han Z; Xu H; Zhao M; Jing F; Xue H; Xiao S
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e77-e88. PubMed ID: 34593361
[TBL] [Abstract][Full Text] [Related]
22. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies.
Wen H; Deng G; Shi X; Liu Z; Lin A; Cheng Q; Zhang J; Luo P
ESMO Open; 2024 Mar; 9(3):102241. PubMed ID: 38442453
[TBL] [Abstract][Full Text] [Related]
23. [Research of prognostic immunophenotypes in 163 patients of diffuse large B-cell lymphoma].
Yang X; Chen S; Qi Y; Xu XY; Guan X; Yang YC; Liu YX; Guo YH; Gong WC; Gao YN; Wang XH; Li W; Li LF; Fu K; Zhang HL; Meng B
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):487-494. PubMed ID: 34384155
[No Abstract] [Full Text] [Related]
24. Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis.
Chen Y; Zhang Z; Fang Q; Jian H
Cancer Cell Int; 2019; 19():245. PubMed ID: 31572062
[TBL] [Abstract][Full Text] [Related]
25. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
27. High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.
Zhou Z; Rademaker AW; Gordon LI; LaCasce AS; Crosby-Thompson A; Vanderplas A; Abel GA; Rodriguez MA; Nademanee A; Kaminski MS; Czuczman MS; Millenson MM; Zelenetz AD; Niland J; Friedberg JW; Winter JN
J Natl Compr Canc Netw; 2016 Oct; 14(10):1274-1281. PubMed ID: 27697981
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis.
Cao D; Zhang Z
Front Oncol; 2023; 13():1169749. PubMed ID: 37064090
[TBL] [Abstract][Full Text] [Related]
29. Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.
Shin DY; Kim A; Byun BH; Moon H; Kim S; Ko YJ; Kim MJ; Lee HR; Kang HJ; Na II; Park S; Lee SS; Yang SH
Ann Hematol; 2016 Feb; 95(3):409-16. PubMed ID: 26658607
[TBL] [Abstract][Full Text] [Related]
30. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
[TBL] [Abstract][Full Text] [Related]
31. Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports.
Sun HL; Pan YQ; He BS; Nie ZL; Lin K; Peng HX; Cho WC; Wang SK
Onco Targets Ther; 2016; 9():3017-23. PubMed ID: 27284252
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis.
Yao L; Xu H; Wo J; Zhao M; Liu Z; Dong T; Xiao S
Clin Exp Med; 2022 Feb; 22(1):1-7. PubMed ID: 33990849
[TBL] [Abstract][Full Text] [Related]
33. Body mass index and mortality in patients with gastric cancer: a large cohort study.
Lee JH; Park B; Joo J; Kook MC; Kim YI; Lee JY; Kim CG; Choi IJ; Eom BW; Yoon HM; Ryu KW; Kim YW; Cho SJ
Gastric Cancer; 2018 Nov; 21(6):913-924. PubMed ID: 29651648
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer - An exploratory analysis.
Verma S; Arora S; Sahoo RK; Singh P; Nayak B; Haresh KP; Das CJ; Shamim SA; Kaushal S; Batra A
Cancer Treat Res Commun; 2022; 31():100520. PubMed ID: 35091358
[TBL] [Abstract][Full Text] [Related]
35. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial.
Doehner W; Schenkel J; Anker SD; Springer J; Audebert HJ
Eur Heart J; 2013 Jan; 34(4):268-77. PubMed ID: 23076781
[TBL] [Abstract][Full Text] [Related]
36. Association between abnormal body weight and stroke outcome: A meta-analysis and systematic review.
Zhang P; Yan XL; Qu Y; Guo ZN; Yang Y
Eur J Neurol; 2021 Aug; 28(8):2552-2564. PubMed ID: 33896081
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of FOXP3
Bai Y; He T; Zhang L; Liu Q; Yang J; Zhao Z; Yang K; Zhang M
BMJ Open; 2022 Sep; 12(9):e060659. PubMed ID: 36691128
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma.
Gao F; Hu J; Zhang J; Xu Y
J Cancer; 2021; 12(12):3407-3417. PubMed ID: 33995619
[No Abstract] [Full Text] [Related]
39. Effect of body mass index on outcomes of peritoneal dialysis patients in India.
Prasad N; Sinha A; Gupta A; Sharma RK; Bhadauria D; Chandra A; Prasad KN; Kaul A
Perit Dial Int; 2014 Jun; 34(4):399-408. PubMed ID: 24584600
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Huang Z; Wang K; Huang S; Lu Q
Transl Cancer Res; 2023 Aug; 12(8):2169-2180. PubMed ID: 37701105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
